Our cancer research spans the entire cancer journey — from prevention and early detection to treatment, survivorship, and palliative care. Our work addresses symptom management, biological behavioral omics, and patient-reported outcomes, leveraging technology, psychology and neuroscience to reduce cancer risk, lower mortality rates, and improve quality of life.

For Early Detection

Precision Medicine and Cachexia

Cancer cachexia — a devastating condition causing severe muscle wasting and weight loss — affects up to 80% of patients with advanced cancer and significantly reduces survival and quality of life. With support from the National Cancer Institute, Assistant Professor Ronald Eldridge is leading groundbreaking research to uncover the biological mechanisms behind this condition in head and neck cancer patients, paving the way for earlier detection, personalized interventions, and improved quality of life.